News Sanofi opens digital biologics manufacturing site Sanofi has opened a manufacturing facility in the US, one of the world’s first facilities using digital continuous biologics production technology.
Events Partner Content Cell and Gene Therapy Manufacturing Forum Last year we told you that the cell and gene industry would be worth $9 - $14 billion by 2026. We were wrong.
Views & Analysis Continuous bioprocessing – the key to industrialising gene t... A new partnership, with funding from Innovate UK, aims to investigate the possibility of using continuous manufacturing processes in gene therapy.
News UK gene and cell therapy manufacturing hub clears regulatory... The UK's regulator has granted new licences to a hub of biotech companies to allow them to continue manufacturing of groundbreaking gene and cell therapies at an innovative purpose-built ce
News Sanofi invests in new Canadian vaccine manufacturing plant Sanofi is investing 350 million euros in a new vaccine manufacturing facility at its Canadian headquarters in Toronto.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
